The latest regulatory evolution from the U.S. Food and Drug Administration is not merely about introducing flexibility in cell and gene therapy (CGT) development—it represents…
The long-running legal saga surrounding Purdue Pharma is approaching a critical milestone. With sentencing in the opioid case expected imminently, the path is being cleared…
The global healthcare ecosystem has long been constrained by one of its most critical bottlenecks: the availability of transplantable human organs. Thousands of patients remain…
The U.S. Food and Drug Administration (FDA) has introduced a more flexible approach to regulating cell and gene therapies (CGTs), particularly in chemistry, manufacturing, and…
The evolving regulatory landscape in digital health is entering a pivotal phase. The U.S. Food and Drug Administration (FDA) is signaling a more flexible approach…
The global food industry is undergoing a structural transformation, driven by sustainability pressures, resource constraints, and evolving consumer preferences. Alternative proteins—once a niche segment—are now…
The global energy transition is no longer a distant ambition—it is an urgent strategic priority. As volatility in fossil fuel markets continues to disrupt supply…
Introduction Decarbonization has moved beyond policy ambition and sustainability pledges—it is now a defining force shaping global competitiveness, capital allocation, and innovation strategies. In 2026,…
The beauty industry has always been driven by innovation—but 2026 marks a structural shift. Artificial Intelligence (AI) is no longer an experimental add-on; it is…